Shockwave therapy, also known as Extracorporeal Shockwave Therapy (ESWT), is a non-invasive medical treatment that utilizes high-energy acoustic waves to induce biological responses within tissues.
The mechanical force exerted by the shockwaves triggers a cascade of cellular events that promote tissue regeneration, neovascularization (the formation of new blood vessels), and pain reduction.
In the context of foot pathology, shockwave therapy is particularly beneficial for conditions like plantar fasciitis, Achilles tendonitis, and heel spurs. Plantar fasciitis, for example, involves inflammation and microtears in the plantar fascia, a thick band of tissue that supports the arch of the foot. Shockwave therapy has been shown to stimulate the release of growth factors, such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), which promote angiogenesis (formation of new blood vessels) and fibroblast proliferation (cells involved in tissue repair), respectively. Additionally, shockwaves can disrupt calcifications, like those found in heel spurs , facilitating their breakdown and subsequent absorption by the body.
Shockwave therapy is performed in the clinical setting by your podiatrist. The procedure is generally well-tolerated and does not require anesthesia, although some patients may experience mild discomfort during treatment. Research indicates that in most cases 3-5 treatments, a week apart are required for the desired outcomes.
Shockwave therapy offers a safe, non-invasive alternative for managing foot pain and promoting tissue healing, making it a valuable option for individuals seeking relief from chronic or acute foot conditions.